Non small cell lung carcinoma

1 paper

Trial sponsors

Hoffmann-La Roche
Company5 trialsPhase 42,041 people
Eli Lilly and Company
Company11 trialsPhase 35,018 people
Merck & Co.
Company9 trialsPhase 33,604 people
Boehringer Ingelheim
Company6 trialsPhase 31,522 people
Bayer
Company5 trialsPhase 32,006 people
Pfizer
Company4 trialsPhase 31,455 people
Bristol Myers Squibb
Company3 trialsPhase 3847 people
Novartis Pharmaceuticals Corporation
Company3 trialsPhase 3341 people

Latest

1 in 12 months

Diagnostics27 Aug

Advancements in CRISPR/Cas Technologies for Sensitive Cancer Detection: Mechanisms, Platforms, and Clinical Translation Roadmap

ReviewCancer